Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
This Hot Line was presented at PCR e-Course 2020
Summary
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
Speaker: David Muller